CUV 1.42% $13.90 clinuvel pharmaceuticals limited

CLINUVEL AVOIDS 2ND STRIKE, AUSSIE BIOTECH GOES FROM STRENGTH TO STRENGTH (possible AFR headline tomorrrow), page-8

  1. 7,705 Posts.
    lightbulb Created with Sketch. 2797
    Thought I might mention a bit about broker reports - the downgrade to a HOLD from BUY (with price target unchanged at ~$37) was cited as the reason for CUV shares falling more than 20%. That is a fallacy,

    ROTFL. Mitsubishi Tanabe are likely have a competing product MT-7117 on the market within three years. They are already in Phase 3 trials for EPP and Phase 2 for Systemic Sclerosis.

    https://www.mt-pharma.co.jp/e/develop/pipeline.html



    HC the Number One source for crackpot conspiracy theories.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.